Glipizide vs. Glimepiride

See how Glipizide and Glimepiride compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Glipizide and glimepiride are both sulfonylureas that lower blood sugar in type 2 diabetes but differ in dosing frequency and formulation options.

  • Glipizide comes in immediate-release and extended-release tablets, while glimepiride is available only as a standard tablet taken once daily.

  • Both drugs carry a risk of low blood sugar and are among the least expensive oral diabetes medications available.

Glipizide vs. Glimepiride Drug Summary

Glipizide

Glipizide is a second-generation sulfonylurea that helps control blood sugar in adults with type 2 diabetes, used alongside diet and exercise. It comes as an immediate-release tablet taken once or twice daily, or an extended-release tablet taken once daily.

Glimepiride

Glimepiride is a sulfonylurea that helps control blood sugar in adults with type 2 diabetes, used alongside diet and exercise. It is taken as a single oral tablet once daily, usually with the first meal, and has no extended-release form.

Glipizide vs. Glimepiride Side Effects

Glipizide

Most common
headache (~2%)
dizziness (~2%)
drowsiness (~2%)
nausea (~1.4%)

Glimepiride

Most common
headache (>5%)
dizziness (>5%)
hypoglycemia (>5%)
asthenia (>5%)

Glipizide vs. Glimepiride Dosage

Glipizide

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once daily At the start
Maximum dose 5-20 mg once daily If needed
Dose changes 5 increases As tolerated

Glimepiride

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 8 mg once daily If needed
Dose changes 3 increases As tolerated

Glipizide vs. Glimepiride Indications

Glipizide

Glipizide is FDA-approved to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are not enough. It is not approved for type 1 diabetes or diabetic ketoacidosis. Doctors often choose it when a low-cost, well-established option is needed.

  • Adjunct to diet and exercise in type 2 diabetes

  • Available in immediate-release and extended-release forms

  • Not for type 1 diabetes or diabetic ketoacidosis

  • Often used when cost is a major concern

Glimepiride

Glimepiride is FDA-approved to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are not enough. It is not approved for type 1 diabetes or diabetic ketoacidosis. It is often chosen for its simple once-daily dosing schedule.

  • Adjunct to diet and exercise in type 2 diabetes

  • Available only as a standard oral tablet

  • Not for type 1 diabetes or diabetic ketoacidosis

  • Often used for its once-daily simplicity

Glipizide vs. Glimepiride Pros and Cons

Glipizide

Glipizide has decades of clinical use and comes in both immediate-release and extended-release forms, adding dosing flexibility. Like other sulfonylureas, it carries hypoglycemia and cardiovascular risks, and is not usually a first-line choice given newer options.

Pros

  • Available in extended-release form for once-daily dosing

  • Long clinical track record since 1984 FDA approval

  • Flexible dosing range to fine-tune blood sugar control

  • Extended-release shell passes through the GI tract predictably

Cons

  • Extended-release tablets cannot be split or crushed

  • Two formulations (IR and ER) can create dosing confusion

  • Higher-end IR dosing requires multiple daily doses

Glimepiride

Glimepiride offers straightforward once-daily dosing and is one of the most affordable sulfonylureas available. It carries the same hypoglycemia and cardiovascular risks as other drugs in its class, and is not recommended in patients with G6PD deficiency.

Pros

  • Simple single-tablet dosing with no extended-release version needed

  • Fewer titration steps to reach an effective maintenance dose

  • FDA approved since 1995 with well-documented safety data

  • Only four dosage strengths simplify prescribing

Cons

  • Risk of hemolytic anemia in patients with G6PD deficiency

  • Must be stopped at least two weeks before delivery in pregnancy

  • Postmarketing reports of severe allergic reactions like Stevens-Johnson syndrome

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.